Polyrizon Ltd. (PLRZ) Insider Trading Activity

NASDAQ$11.125-0.28 (-2.46%)
Market Cap
$12.78M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
717 of 849
Rank in Industry
410 of 491

PLRZ Insider Trading Activity

PLRZ Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$132,642
6
100

Related Transactions

Carmel Lirondirector
0
$0
2
$12,743
$-12,743
Turgeman TidharChief Technology Officer
0
$0
1
$31,795
$-31,795
Adler Ozdirector
0
$0
1
$39,669
$-39,669
Izraeli TomerChief Executive Officer
0
$0
2
$48,435
$-48,435

About Polyrizon Ltd.

Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from …

Insider Activity of Polyrizon Ltd.

Over the last 12 months, insiders at Polyrizon Ltd. have bought $0 and sold $132,642 worth of Polyrizon Ltd. stock.

On average, over the past 5 years, insiders at Polyrizon Ltd. have bought $0 and sold $132,642 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, Polyrizon Ltd.

2026-03-31SaleIzraeli TomerChief Executive Officer
500
0.0487%
$11.85
$5,925
-1.24%
2026-03-31SaleAdler Ozdirector
3,292
0.326%
$12.05
$39,669
-1.24%
2026-03-31SaleCarmel Lirondirector
942
0.0957%
$12.36
$11,643
-1.24%
2026-03-30SaleIzraeli TomerChief Executive Officer
3,900
0.3435%
$10.90
$42,510
-2.53%
2026-03-30SaleTurgeman TidharChief Technology Officer
2,917
0.2569%
$10.90
$31,795
-2.53%
2026-03-30SaleCarmel Lirondirector
100
0.0089%
$11.00
$1,100
-2.53%
Total: 6
*Gray background shows transactions not older than one year

PLRZ Institutional Investors: Active Positions

Increased Positions<1+25%14,032+679.84%
Decreased Positions2-50%1,026-49.71%
New Positions<1New14,032New
Sold Out Positions0Sold Out0Sold Out
Total Postitions3-25%15,070+630.14%

PLRZ Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.